Considering the association of DDIT4 with a worse prognosis in human patients with acute myeloid leukemia, glioblastoma multiform, colon, skin and lung cancers in addition to breast cancer [30], future preclinical and clinical studies should determine the real importance of this gene in the response of various cancer types to oncolytic VV. The gene discussed is DDIT4; the disease is breast carcinoma.